CN113331415A - 一种供睡眠障碍人群食用的药膳 - Google Patents
一种供睡眠障碍人群食用的药膳 Download PDFInfo
- Publication number
- CN113331415A CN113331415A CN202110611470.1A CN202110611470A CN113331415A CN 113331415 A CN113331415 A CN 113331415A CN 202110611470 A CN202110611470 A CN 202110611470A CN 113331415 A CN113331415 A CN 113331415A
- Authority
- CN
- China
- Prior art keywords
- parts
- sleep
- people
- sleep disorder
- nourish
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000019116 sleep disease Diseases 0.000 title claims abstract description 28
- 230000037213 diet Effects 0.000 title claims abstract description 17
- 235000005911 diet Nutrition 0.000 title claims abstract description 17
- 208000020685 sleep-wake disease Diseases 0.000 title abstract description 17
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 claims abstract description 28
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 claims abstract description 28
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims abstract description 28
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 claims abstract description 14
- 240000001008 Dimocarpus longan Species 0.000 claims abstract description 14
- 235000000235 Euphoria longan Nutrition 0.000 claims abstract description 14
- 241000234435 Lilium Species 0.000 claims abstract description 14
- 240000002853 Nelumbo nucifera Species 0.000 claims abstract description 14
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims abstract description 14
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims abstract description 14
- 241000237502 Ostreidae Species 0.000 claims abstract description 14
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 14
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 14
- 244000197580 Poria cocos Species 0.000 claims abstract description 14
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 14
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 claims abstract description 14
- 235000020661 alpha-linolenic acid Nutrition 0.000 claims abstract description 14
- 229960003692 gamma aminobutyric acid Drugs 0.000 claims abstract description 14
- 235000008434 ginseng Nutrition 0.000 claims abstract description 14
- 229960004488 linolenic acid Drugs 0.000 claims abstract description 14
- 235000020636 oyster Nutrition 0.000 claims abstract description 14
- 229960003080 taurine Drugs 0.000 claims abstract description 14
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims abstract description 12
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims abstract description 12
- 229910052791 calcium Inorganic materials 0.000 claims abstract description 12
- 239000011575 calcium Substances 0.000 claims abstract description 12
- 229910052749 magnesium Inorganic materials 0.000 claims abstract description 12
- 239000011777 magnesium Substances 0.000 claims abstract description 12
- 241000222336 Ganoderma Species 0.000 claims abstract description 9
- 244000241838 Lycium barbarum Species 0.000 claims abstract description 4
- 235000015459 Lycium barbarum Nutrition 0.000 claims abstract description 4
- 235000015468 Lycium chinense Nutrition 0.000 claims abstract description 4
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 4
- 244000131316 Panax pseudoginseng Species 0.000 claims abstract 3
- 240000001949 Taraxacum officinale Species 0.000 claims abstract 3
- 235000017784 Mespilus germanica Nutrition 0.000 claims description 10
- 244000182216 Mimusops elengi Species 0.000 claims description 10
- 235000000560 Mimusops elengi Nutrition 0.000 claims description 10
- 235000007837 Vangueria infausta Nutrition 0.000 claims description 10
- 240000008397 Ganoderma lucidum Species 0.000 claims description 5
- 235000001637 Ganoderma lucidum Nutrition 0.000 claims description 5
- 230000007958 sleep Effects 0.000 abstract description 22
- 238000011282 treatment Methods 0.000 abstract description 13
- 210000004556 brain Anatomy 0.000 abstract description 10
- 210000002216 heart Anatomy 0.000 abstract description 10
- 239000008280 blood Substances 0.000 abstract description 8
- 210000004369 blood Anatomy 0.000 abstract description 8
- 210000003734 kidney Anatomy 0.000 abstract description 6
- 210000004185 liver Anatomy 0.000 abstract description 6
- 210000000952 spleen Anatomy 0.000 abstract description 6
- 206010033557 Palpitations Diseases 0.000 abstract description 5
- 210000002784 stomach Anatomy 0.000 abstract description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract description 3
- 210000001124 body fluid Anatomy 0.000 abstract description 3
- 239000010839 body fluid Substances 0.000 abstract description 3
- 238000004519 manufacturing process Methods 0.000 abstract description 3
- 229910052760 oxygen Inorganic materials 0.000 abstract description 3
- 239000001301 oxygen Substances 0.000 abstract description 3
- 230000001737 promoting effect Effects 0.000 abstract description 3
- 230000001105 regulatory effect Effects 0.000 abstract description 2
- 230000008344 brain blood flow Effects 0.000 abstract 1
- 230000004060 metabolic process Effects 0.000 abstract 1
- 230000002936 tranquilizing effect Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 description 22
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 18
- 206010022437 insomnia Diseases 0.000 description 18
- 241000208340 Araliaceae Species 0.000 description 11
- 241000245665 Taraxacum Species 0.000 description 11
- 238000002560 therapeutic procedure Methods 0.000 description 11
- 238000001467 acupuncture Methods 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 208000011580 syndromic disease Diseases 0.000 description 6
- 230000000694 effects Effects 0.000 description 5
- SVUOLADPCWQTTE-UHFFFAOYSA-N 1h-1,2-benzodiazepine Chemical compound N1N=CC=CC2=CC=CC=C12 SVUOLADPCWQTTE-UHFFFAOYSA-N 0.000 description 4
- 239000011248 coating agent Substances 0.000 description 4
- 238000000576 coating method Methods 0.000 description 4
- 238000007689 inspection Methods 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 210000005036 nerve Anatomy 0.000 description 4
- 238000012856 packing Methods 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 238000005728 strengthening Methods 0.000 description 4
- 229940126673 western medicines Drugs 0.000 description 4
- 235000001188 Peltandra virginica Nutrition 0.000 description 3
- 239000000556 agonist Substances 0.000 description 3
- 239000000935 antidepressant agent Substances 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 229940053999 hypnotics and sedatives melatonin receptor agonists Drugs 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 230000003860 sleep quality Effects 0.000 description 3
- 229960001475 zolpidem Drugs 0.000 description 3
- ZAFYATHCZYHLPB-UHFFFAOYSA-N zolpidem Chemical compound N1=C2C=CC(C)=CN2C(CC(=O)N(C)C)=C1C1=CC=C(C)C=C1 ZAFYATHCZYHLPB-UHFFFAOYSA-N 0.000 description 3
- AHOUBRCZNHFOSL-YOEHRIQHSA-N (+)-Casbol Chemical compound C1=CC(F)=CC=C1[C@H]1[C@H](COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-YOEHRIQHSA-N 0.000 description 2
- 208000000044 Amnesia Diseases 0.000 description 2
- 208000031091 Amnestic disease Diseases 0.000 description 2
- 208000019901 Anxiety disease Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- AHOUBRCZNHFOSL-UHFFFAOYSA-N Paroxetine hydrochloride Natural products C1=CC(F)=CC=C1C1C(COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-UHFFFAOYSA-N 0.000 description 2
- 206010062519 Poor quality sleep Diseases 0.000 description 2
- 230000006986 amnesia Effects 0.000 description 2
- 230000036506 anxiety Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000001914 calming effect Effects 0.000 description 2
- 230000001149 cognitive effect Effects 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 206010016256 fatigue Diseases 0.000 description 2
- 229910001385 heavy metal Inorganic materials 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 230000007102 metabolic function Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 229960002296 paroxetine Drugs 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 238000007711 solidification Methods 0.000 description 2
- 230000008023 solidification Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 229940126680 traditional chinese medicines Drugs 0.000 description 2
- 230000002618 waking effect Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- GBBSUAFBMRNDJC-MRXNPFEDSA-N (5R)-zopiclone Chemical compound C1CN(C)CCN1C(=O)O[C@@H]1C2=NC=CN=C2C(=O)N1C1=CC=C(Cl)C=N1 GBBSUAFBMRNDJC-MRXNPFEDSA-N 0.000 description 1
- RTHCYVBBDHJXIQ-MRXNPFEDSA-N (R)-fluoxetine Chemical compound O([C@H](CCNC)C=1C=CC=CC=1)C1=CC=C(C(F)(F)F)C=C1 RTHCYVBBDHJXIQ-MRXNPFEDSA-N 0.000 description 1
- ZEUITGRIYCTCEM-KRWDZBQOSA-N (S)-duloxetine Chemical compound C1([C@@H](OC=2C3=CC=CC=C3C=CC=2)CCNC)=CC=CS1 ZEUITGRIYCTCEM-KRWDZBQOSA-N 0.000 description 1
- LQIAZOCLNBBZQK-UHFFFAOYSA-N 1-(1,2-Diphosphanylethyl)pyrrolidin-2-one Chemical compound PCC(P)N1CCCC1=O LQIAZOCLNBBZQK-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 206010008796 Chromaturia Diseases 0.000 description 1
- 206010010305 Confusional state Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 101100136092 Drosophila melanogaster peng gene Proteins 0.000 description 1
- 206010013789 Dry throat Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 208000027534 Emotional disease Diseases 0.000 description 1
- 206010015137 Eructation Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 206010024642 Listless Diseases 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- YJPIGAIKUZMOQA-UHFFFAOYSA-N Melatonin Natural products COC1=CC=C2N(C(C)=O)C=C(CCN)C2=C1 YJPIGAIKUZMOQA-UHFFFAOYSA-N 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- YLXDSYKOBKBWJQ-LBPRGKRZSA-N N-[2-[(8S)-2,6,7,8-tetrahydro-1H-cyclopenta[e]benzofuran-8-yl]ethyl]propanamide Chemical compound C1=C2OCCC2=C2[C@H](CCNC(=O)CC)CCC2=C1 YLXDSYKOBKBWJQ-LBPRGKRZSA-N 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 206010041497 Spermatorrhoea Diseases 0.000 description 1
- SEQDDYPDSLOBDC-UHFFFAOYSA-N Temazepam Chemical compound N=1C(O)C(=O)N(C)C2=CC=C(Cl)C=C2C=1C1=CC=CC=C1 SEQDDYPDSLOBDC-UHFFFAOYSA-N 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 229940123445 Tricyclic antidepressant Drugs 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- FZKXFLIDQDMHBH-UHFFFAOYSA-N [N].[N].C1=CC=CC=C1 Chemical compound [N].[N].C1=CC=CC=C1 FZKXFLIDQDMHBH-UHFFFAOYSA-N 0.000 description 1
- 206010000059 abdominal discomfort Diseases 0.000 description 1
- 229960002629 agomelatine Drugs 0.000 description 1
- YJYPHIXNFHFHND-UHFFFAOYSA-N agomelatine Chemical compound C1=CC=C(CCNC(C)=O)C2=CC(OC)=CC=C21 YJYPHIXNFHFHND-UHFFFAOYSA-N 0.000 description 1
- 230000001430 anti-depressive effect Effects 0.000 description 1
- 229940005513 antidepressants Drugs 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 238000013542 behavioral therapy Methods 0.000 description 1
- 208000027687 belching Diseases 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 239000002729 catgut Substances 0.000 description 1
- 238000013270 controlled release Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 229960003529 diazepam Drugs 0.000 description 1
- AAOVKJBEBIDNHE-UHFFFAOYSA-N diazepam Chemical compound N=1CC(=O)N(C)C2=CC=C(Cl)C=C2C=1C1=CC=CC=C1 AAOVKJBEBIDNHE-UHFFFAOYSA-N 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229960002866 duloxetine Drugs 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229960002336 estazolam Drugs 0.000 description 1
- CDCHDCWJMGXXRH-UHFFFAOYSA-N estazolam Chemical compound C=1C(Cl)=CC=C(N2C=NN=C2CN=2)C=1C=2C1=CC=CC=C1 CDCHDCWJMGXXRH-UHFFFAOYSA-N 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 229960002464 fluoxetine Drugs 0.000 description 1
- 229960003528 flurazepam Drugs 0.000 description 1
- SAADBVWGJQAEFS-UHFFFAOYSA-N flurazepam Chemical compound N=1CC(=O)N(CCN(CC)CC)C2=CC=C(Cl)C=C2C=1C1=CC=CC=C1F SAADBVWGJQAEFS-UHFFFAOYSA-N 0.000 description 1
- 229960004038 fluvoxamine Drugs 0.000 description 1
- CJOFXWAVKWHTFT-XSFVSMFZSA-N fluvoxamine Chemical compound COCCCC\C(=N/OCCN)C1=CC=C(C(F)(F)F)C=C1 CJOFXWAVKWHTFT-XSFVSMFZSA-N 0.000 description 1
- 239000008941 guipiwan Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000000147 hypnotic effect Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 208000017971 listlessness Diseases 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- DRLFMBDRBRZALE-UHFFFAOYSA-N melatonin Chemical compound COC1=CC=C2NC=C(CCNC(C)=O)C2=C1 DRLFMBDRBRZALE-UHFFFAOYSA-N 0.000 description 1
- 230000007087 memory ability Effects 0.000 description 1
- 230000006996 mental state Effects 0.000 description 1
- 229960001785 mirtazapine Drugs 0.000 description 1
- RONZAEMNMFQXRA-UHFFFAOYSA-N mirtazapine Chemical compound C1C2=CC=CN=C2N2CCN(C)CC2C2=CC=CC=C21 RONZAEMNMFQXRA-UHFFFAOYSA-N 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 239000002767 noradrenalin uptake inhibitor Substances 0.000 description 1
- 229940127221 norepinephrine reuptake inhibitor Drugs 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- 238000001671 psychotherapy Methods 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 229960001150 ramelteon Drugs 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 239000003772 serotonin uptake inhibitor Substances 0.000 description 1
- 229960002073 sertraline Drugs 0.000 description 1
- VGKDLMBJGBXTGI-SJCJKPOMSA-N sertraline Chemical compound C1([C@@H]2CC[C@@H](C3=CC=CC=C32)NC)=CC=C(Cl)C(Cl)=C1 VGKDLMBJGBXTGI-SJCJKPOMSA-N 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 230000004622 sleep time Effects 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 229960003188 temazepam Drugs 0.000 description 1
- -1 tesmedetone Chemical compound 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 238000011491 transcranial magnetic stimulation Methods 0.000 description 1
- 229960003991 trazodone Drugs 0.000 description 1
- PHLBKPHSAVXXEF-UHFFFAOYSA-N trazodone Chemical compound ClC1=CC=CC(N2CCN(CCCN3C(N4C=CC=CC4=N3)=O)CC2)=C1 PHLBKPHSAVXXEF-UHFFFAOYSA-N 0.000 description 1
- 239000003029 tricyclic antidepressant agent Substances 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 229960004688 venlafaxine Drugs 0.000 description 1
- PNVNVHUZROJLTJ-UHFFFAOYSA-N venlafaxine Chemical compound C1=CC(OC)=CC=C1C(CN(C)C)C1(O)CCCCC1 PNVNVHUZROJLTJ-UHFFFAOYSA-N 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 229960004010 zaleplon Drugs 0.000 description 1
- HUNXMJYCHXQEGX-UHFFFAOYSA-N zaleplon Chemical compound CCN(C(C)=O)C1=CC=CC(C=2N3N=CC(=C3N=CC=2)C#N)=C1 HUNXMJYCHXQEGX-UHFFFAOYSA-N 0.000 description 1
- 229960000820 zopiclone Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L17/00—Food-from-the-sea products; Fish products; Fish meal; Fish-egg substitutes; Preparation or treatment thereof
- A23L17/50—Molluscs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/074—Ganoderma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/62—Nymphaeaceae (Water-lily family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/77—Sapindaceae (Soapberry family), e.g. lychee or soapberry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8967—Lilium, e.g. tiger lily or Easter lily
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8969—Polygonatum (Solomon's seal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Marine Sciences & Fisheries (AREA)
- Zoology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Anesthesiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
一种供睡眠障碍人群食用的药膳,涉及药膳领域,解决了现有几种睡眠障碍治疗方案存在的问题。本发明按重量份数计包括:人参1000~3000份、黄精1000~3000份、枸杞子1000~3000份、茯苓1000~3000份、龙眼肉1000~3000份、牡蛎1000~3000份、酸枣仁1000~3000份、百合1000~3000份、蒲公英1000~3000份、灵芝1000~3000份、莲子1000~3000份、钙200~1000份、镁200~500份、α‑亚麻酸1000~3000份、γ‑氨基丁酸100~1000份、牛磺酸100~1000份。本发明能补气养阴、生津养血、健脾和胃、滋补肝肾、养心安神、定魂魄、止惊悸、少梦安眠;改善脑部血液循环,提高脑部血液含氧量,促进脑的代谢功能,镇定安神;消除引起睡眠障碍的危险因素,调节睡眠,预防睡眠障碍引发的各种并发症。
Description
技术领域
本发明涉及一种药膳,具体涉及一种供睡眠障碍人群食用的药膳。
背景技术
睡眠障碍是指各种原因引起的睡眠时间和(或)睡眠质量的改变,并导致日间社会功能受到影响的疾病,包括心理生理性失眠、睡眠状态感知不良、特发性失眠、入睡困难等。
随着生活压力的增大,社会竞争的日益加剧,人们承受的生理、心理压力越来越大,失眠的发生率逐年攀升。长期失眠不仅严重影响了人们的身体健康,导致肥胖、糖尿病、高血压等,降低人们的生活质量,还可能导致学习、记忆能力的下降,严重者可导致焦虑症、抑郁症等精神障碍。
一、中医治疗
睡眠障碍属于中医学“不寐”的范围。中医学认为不寐与心、脾、肝、肾关系最为密切,其病因主要为饮食不节,情志失常,劳倦、思虑过度及病后、年迈体虚等因素。病理变化总属阳不入阴,阴阳失交。邪扰心神或心神失养而导致阳不交阴或神不守舍而发生不寐。治疗当以补虚泻实,调整脏腑气血阴阳为原则。
1.辨证治疗
1)肝火扰心
证候特点:不寐,性情急躁易怒,不思饮食,口渴喜饮,目赤口苦,小便黄赤,大便秘结,舌红,苔黄,脉弦而数。
治法:疏肝泻火,清脑安神。
2)胃气失和
证候特点:胸闷嗳气,脘腹不适而不寐,恶心呕吐,大便不爽,腹痛,舌苔黄腻或黄燥,脉象弦滑或滑数。
治法:和胃化滞,升阳安神。
3)心脾两虚
证候特点:患者不易入眠,或睡中梦多,易醒再难入睡,兼见心悸健忘,头晕目眩,肢倦神疲,饮食无味,面色少华,舌质淡,苔薄白,脉细弱。
治法:补益心脾,养血安神。
4)心肾不交
证候特点:心烦不寐,头晕耳鸣,烦热盗汗,咽干,精神萎靡,健忘,腰膝酸软;男子滑精阳痿,女子月经不调,舌红少苔,脉细数。
治法:交通心肾,补脑安神。
5)心胆气虚
证候特点:不寐多梦,易于惊醒,胆怯心悸,遇事善惊,气短倦怠,小便清长,舌淡,脉弦细。
治法:补益心气,安神定志。
2.中成药治疗
常用的中成药:归脾丸、逍遥丸、天王补心丹、朱砂安神丸等。
3.针灸
针灸治疗包括体针、耳针、梅花针、灸法、放血疗法、电针、穴位埋线等。
4.其他治疗
其他治疗包括推拿按摩、经颅磁刺激疗法、电子生物反馈治疗、音乐治疗、中药足疗等。
近年来开展的中医辨证治疗为主体的临床研究,深化了中医对睡眠障碍的认识。对于一般的原发性失眠采用中药汤剂、针灸治疗等为主,结合睡眠认知行为进行治疗;对于一些顽固性慢性失眠,则结合西药进行治疗。但中医对睡眠障碍的临床研究缺少统一的观察指标,而且药味较多,不利于进一步的中药新药开发研究。
二、西医治疗
1.药物治疗
2)褪黑素和褪黑素受体激动剂:雷美尔通、特斯美尔通、阿戈美拉汀。
3)抗抑郁药物:
①三环类抗抑郁药物:多塞平;
②选择性5-羟色胺再摄取抑制剂:氟西汀、帕罗西汀、舍曲林、氟伏沙明;
③5-羟色胺和去甲肾上腺素再摄取抑制剂:文拉法辛、度洛西汀;
④其他抗抑郁药物:米氮平、曲唑酮;
2.心理治疗
心理治疗主要包括:睡眠卫生教育、松弛疗法、刺激控制疗法、睡眠限制疗法、认知行为治疗等。
西药治疗见效快,但药物副作用大,且停药困难,若不规范使用也可能形成药物依赖。
发明内容
为了解决中西药在治疗睡眠障碍疾病中存在的诸多问题,本发明提供了一种供睡眠障碍人群食用的药膳。
本发明为解决技术问题所采用的技术方案如下:
本发明的一种供睡眠障碍人群食用的药膳,按照重量份数计包括以下组份:
人参1000~3000份、黄精1000~3000份、枸杞子1000~3000份、茯苓1000~3000份、龙眼肉1000~3000份、牡蛎1000~3000份、酸枣仁1000~3000份、百合1000~3000份、蒲公英1000~3000份、灵芝1000~3000份、莲子1000~3000份、钙200~1000份、镁200~500份、α-亚麻酸1000~3000份、γ-氨基丁酸100~1000份、牛磺酸100~1000份。
作为优选的实施方式,本发明的一种供睡眠障碍人群食用的药膳,按照重量份数计包括以下组份:
人参1500份、黄精1500份、枸杞子1500份、茯苓1500份、龙眼肉1500份、牡蛎1500份、酸枣仁1500份、百合1500份、蒲公英1500份、灵芝1500份、莲子1500份、钙500份、镁300份、α-亚麻酸1500份、γ-氨基丁酸700份、牛磺酸500份。
本发明的有益效果是:本发明是由人参、黄精、枸杞子、茯苓、龙眼肉、牡蛎、酸枣仁、百合、蒲公英、灵芝、莲子等食药物质组成,诸品合用,有补气养阴、生津养血、健脾和胃、滋补肝肾、养心安神、定魂魄、止惊悸、少梦安眠的作用;以α-亚麻酸、γ-氨基丁酸、牛磺酸等组成精准营养强化部分,能够改善脑部血液循环,提高脑部血液含氧量,促进脑的代谢功能,镇定安神,调节睡眠。
经过十几年来的临床验证证明,本发明的一种供睡眠障碍人群食用的药膳可以消除引起睡眠障碍的危险因素,调节睡眠,预防睡眠障碍引发的各种并发症。
另外,本发明所使用的食药物质和营养强化物质安全、无毒副作用。
具体实施方式
本发明的一种供睡眠障碍人群食用的药膳,按照重量份数计包括以下组份:
人参1000~3000份、黄精1000~3000份、枸杞子1000~3000份、茯苓1000~3000份、龙眼肉1000~3000份、牡蛎1000~3000份、酸枣仁1000~3000份、百合1000~3000份、蒲公英1000~3000份、灵芝1000~3000份、莲子1000~3000份、钙200~1000份、镁200~500份、α-亚麻酸1000~3000份、γ-氨基丁酸100~1000份、牛磺酸100~1000份。
本发明中各组份的作用及功效如下:
本发明由人参、黄精、枸杞子、茯苓、龙眼肉、牡蛎、酸枣仁、百合、蒲公英、灵芝、莲子等食药物质组成,诸品合用,有补气养阴、生津养血、健脾和胃、滋补肝肾、养心安神、定魂魄、止惊悸、少梦安眠的作用。
本发明以α-亚麻酸、γ-氨基丁酸、牛磺酸等组成精准营养强化部分,能够改善脑部血液循环,提高脑部血液含氧量,促进脑的代谢功能,镇定安神,调节睡眠。
本发明的一种供睡眠障碍人群食用的药膳的制备方法具体包括以下步骤:
①按照本发明的组份及用量称取原料备用;
②将全部原料依次投入混料机内,混合均匀,以没有结块、结固为准,密封备用;
③将混匀后的复合粉投入真空干燥机内进行干燥;
④取样检测重金属、微生物;
⑤检测不合格的混料,按原因进行重新处理,合格的混料进行分装;
⑥分装后的产品进入外包装室进行外包装;
⑦现场进行质量检验,合格后入库。
本发明的一种供睡眠障碍人群食用的药膳的食用方法:
取本品1袋,温水冲泡,搅拌均匀,待温度适宜后即可食用。每次1袋,每日2次。
下面将结合本发明实施例,对本发明实施例中的技术方案进行清楚、完整地描述,显然,所描述的实施例仅仅是本发明一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。
实施例1
本实施例的具体组份及用量如下:
人参1500份、黄精1500份、枸杞子1500份、茯苓1500份、龙眼肉1500份、牡蛎1500份、酸枣仁1500份、百合1500份、蒲公英1500份、灵芝1500份、莲子1500份、钙500份、镁300份、α-亚麻酸1500份、γ-氨基丁酸700份、牛磺酸500份。
本实施例的制备过程如下:
①按照本发明的组份及用量称取原料备用;
②将全部原料依次投入混料机内,混合均匀,以没有结块、结固为准,密封备用;
③将混匀后的复合粉投入真空干燥机内进行干燥;
④取样检测重金属、微生物;
⑤检测不合格的混料,按原因进行重新处理,合格的混料进行分装;
⑥分装后的产品进入外包装室进行外包装;
⑦现场进行质量检验,合格后入库。
实施例2
本实施例的具体组份及用量如下:
人参1500份、黄精1450份、枸杞子1550份、茯苓1200份、龙眼肉1400份、牡蛎1500份、酸枣仁1500份、百合1600份、蒲公英1600份、灵芝1500份、莲子1600份、钙500份、镁300份、α-亚麻酸1600份、γ-氨基丁酸700份、牛磺酸500份。
本实施例的制备过程与实施例1相同。
实施例3
本实施例的具体组份及用量如下:
人参1500份、黄精1400份、枸杞子1500份、茯苓1600份、龙眼肉1500份、牡蛎1500份、酸枣仁1600份、百合1400份、蒲公英1550份、灵芝1450份、莲子1500份、钙500份、镁300份、α-亚麻酸1500份、γ-氨基丁酸700份、牛磺酸500份。
本实施例的制备过程与实施例1相同。
实施例4
本实施例的具体组份及用量如下:
人参1450份、黄精1500份、枸杞子1450份、茯苓1550份、龙眼肉1500份、牡蛎1500份、酸枣仁1550份、百合1550份、蒲公英1550份、灵芝1400份、莲子1550份、钙400份、镁300份、α-亚麻酸1500份、γ-氨基丁酸700份、牛磺酸550份。
本实施例的制备过程与实施例1相同。
实施例5
本实施例的具体组份及用量如下:
人参1500份、黄精1550份、枸杞子1400份、茯苓1550份、龙眼肉1500份、牡蛎1450份、酸枣仁1600份、百合1550份、蒲公英1450份、灵芝1400份、莲子1550份、钙450份、镁300份、α-亚麻酸1550份、γ-氨基丁酸700份、牛磺酸500份。
本实施例的制备过程与实施例1相同。
实施例6
本实施例的具体组份及用量如下:
人参1400份、黄精1500份、枸杞子1600份、茯苓1550份、龙眼肉1400份、牡蛎1400份、酸枣仁1600份、百合1550份、蒲公英1500份、灵芝1500份、莲子1550份、钙450份、镁300份、α-亚麻酸1550份、γ-氨基丁酸700份、牛磺酸450份。
本实施例的制备过程与实施例1相同。
临床试验
案例1:睡眠障碍
患者姓名:彭某某
年龄:51岁
性别:女
职业:无
医院诊断:失眠、多梦、易醒
2021年一月份失眠加重,连续几天晚上无法入睡。之前依赖药物助眠,看过两次中医,效果不理想。服用本发明50天后,睡眠得到明显改善,虽然凌晨4、5点还会醒一下,但是还能接着睡着,直到6、7点钟起床。
案例2:睡眠障碍
患者姓名:张某某
年龄:61岁
性别:女
职业:退休老人
医院诊断:睡眠质量差、多梦、易醒
服用本发明前一直睡眠质量差,易醒,晚上睡不踏实,醒后短时间内无法继续入睡。服用本发明60天后,晚上虽然有时还会醒,但其他失眠症状都改善了,白天的精神状态也比之前强很多。
案例3:睡眠障碍
患者姓名:胡某某
年龄:52岁
性别:女
职业:无
医院诊断:睡眠障碍
服用本发明前一直睡眠质量差、多梦,整夜睡不着,即使睡着了,也只能睡2、3个小时。自从服用本发明,手脚不凉了;服用本发明50天后,每日早起精神明显好转,身上有力气了,也不犯困了,晚上也能睡得安稳。
本发明公开了一种供睡眠障碍人群食用的药膳,本领域技术人员可以借鉴本文内容,适当改进工艺参数实现。特别需要指出的是,所有类似的替换和改动对本领域技术人员来说是显而易见的,它们都被视为包括在本发明。本发明的产品已经通过较佳实施例进行了描述,相关人员明显能在不脱离本发明内容、精神和范围内对本文所述的产品进行改动或适当变更与组合,来实现和应用本发明技术。
Claims (2)
1.一种供睡眠障碍人群食用的药膳,其特征在于,按照重量份数计包括以下组份:
人参1000~3000份、黄精1000~3000份、枸杞子1000~3000份、茯苓1000~3000份、龙眼肉1000~3000份、牡蛎1000~3000份、酸枣仁1000~3000份、百合1000~3000份、蒲公英1000~3000份、灵芝1000~3000份、莲子1000~3000份、钙200~1000份、镁200~500份、α-亚麻酸1000~3000份、γ-氨基丁酸100~1000份、牛磺酸100~1000份。
2.根据权利要求1所述的一种供睡眠障碍人群食用的药膳,其特征在于,按照重量份数计包括以下组份:
人参1500份、黄精1500份、枸杞子1500份、茯苓1500份、龙眼肉1500份、牡蛎1500份、酸枣仁1500份、百合1500份、蒲公英1500份、灵芝1500份、莲子1500份、钙500份、镁300份、α-亚麻酸1500份、γ-氨基丁酸700份、牛磺酸500份。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110611470.1A CN113331415A (zh) | 2021-06-02 | 2021-06-02 | 一种供睡眠障碍人群食用的药膳 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110611470.1A CN113331415A (zh) | 2021-06-02 | 2021-06-02 | 一种供睡眠障碍人群食用的药膳 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN113331415A true CN113331415A (zh) | 2021-09-03 |
Family
ID=77474624
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110611470.1A Pending CN113331415A (zh) | 2021-06-02 | 2021-06-02 | 一种供睡眠障碍人群食用的药膳 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113331415A (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113243531A (zh) * | 2021-06-02 | 2021-08-13 | 膳行天下(吉林)科技发展有限公司 | 一种供高尿酸人群食用的药膳 |
CN114376039A (zh) * | 2021-12-25 | 2022-04-22 | 宁波荟康生命科技有限公司 | 一种用于安神、改善睡眠的复合果茶及其制备方法 |
Citations (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1057483A1 (en) * | 1998-02-23 | 2000-12-06 | Taiyo Kagaku Co., Ltd. | Composition comprising theanine |
CN1418945A (zh) * | 2002-11-03 | 2003-05-21 | 贵州佰仕特制药有限责任公司 | 芪参虫草酒及其制备工艺 |
CN102293301A (zh) * | 2011-08-26 | 2011-12-28 | 天津尖峰弗兰德医药科技发展有限公司 | 一种具有催眠作用的保健茶及制备方法 |
CN102764340A (zh) * | 2012-08-14 | 2012-11-07 | 中国热带农业科学院热带生物技术研究所 | 一种改善睡眠的中药组合物及其制备方法和应用 |
CN106038970A (zh) * | 2016-06-28 | 2016-10-26 | 杨文礼 | 一种安神助眠养生药酒及其制备方法 |
CN106924628A (zh) * | 2017-04-12 | 2017-07-07 | 吉林省德葆康医药科技股份有限公司 | 用于改善睡眠的中药组合物及其制备方法 |
CN107184857A (zh) * | 2017-07-21 | 2017-09-22 | 成都美淼生物科技有限公司 | 一种用于改善睡眠的保健品 |
CN108042699A (zh) * | 2018-01-19 | 2018-05-18 | 山东仁迪生物工程集团有限公司 | 一种治疗失眠的药物组合物、制剂及其制备方法 |
CN110038085A (zh) * | 2019-05-16 | 2019-07-23 | 徐州绿之野生物食品有限公司 | 一种复方酸枣仁组合提取物的制备方法和用途 |
CN110772595A (zh) * | 2019-11-18 | 2020-02-11 | 黄泽昊 | 一种药食同源组合物及其制备方法和应用 |
CN110839728A (zh) * | 2019-11-15 | 2020-02-28 | 刘永 | 一种人参酸枣仁安神增强免疫力养生茶及其制备方法 |
CN111000232A (zh) * | 2019-11-08 | 2020-04-14 | 李本强 | 一种失眠用中药药膳 |
CN111714581A (zh) * | 2020-07-22 | 2020-09-29 | 江西仁仁健康产业有限公司 | 一种助眠酵素及制备方法 |
CN113244367A (zh) * | 2021-06-02 | 2021-08-13 | 膳行天下(吉林)科技发展有限公司 | 一种供高血脂人群食用的药膳 |
CN113841892A (zh) * | 2021-09-24 | 2021-12-28 | 山西凉方科技有限公司 | 具有助眠功能的食品配方及制备方法和应用 |
-
2021
- 2021-06-02 CN CN202110611470.1A patent/CN113331415A/zh active Pending
Patent Citations (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1057483A1 (en) * | 1998-02-23 | 2000-12-06 | Taiyo Kagaku Co., Ltd. | Composition comprising theanine |
US6831103B1 (en) * | 1998-02-23 | 2004-12-14 | Taiyo Kagaku Co., Ltd. | Composition comprising theanine |
CN1418945A (zh) * | 2002-11-03 | 2003-05-21 | 贵州佰仕特制药有限责任公司 | 芪参虫草酒及其制备工艺 |
CN102293301A (zh) * | 2011-08-26 | 2011-12-28 | 天津尖峰弗兰德医药科技发展有限公司 | 一种具有催眠作用的保健茶及制备方法 |
CN102764340A (zh) * | 2012-08-14 | 2012-11-07 | 中国热带农业科学院热带生物技术研究所 | 一种改善睡眠的中药组合物及其制备方法和应用 |
CN106038970A (zh) * | 2016-06-28 | 2016-10-26 | 杨文礼 | 一种安神助眠养生药酒及其制备方法 |
CN106924628A (zh) * | 2017-04-12 | 2017-07-07 | 吉林省德葆康医药科技股份有限公司 | 用于改善睡眠的中药组合物及其制备方法 |
CN107184857A (zh) * | 2017-07-21 | 2017-09-22 | 成都美淼生物科技有限公司 | 一种用于改善睡眠的保健品 |
CN108042699A (zh) * | 2018-01-19 | 2018-05-18 | 山东仁迪生物工程集团有限公司 | 一种治疗失眠的药物组合物、制剂及其制备方法 |
CN110038085A (zh) * | 2019-05-16 | 2019-07-23 | 徐州绿之野生物食品有限公司 | 一种复方酸枣仁组合提取物的制备方法和用途 |
CN111000232A (zh) * | 2019-11-08 | 2020-04-14 | 李本强 | 一种失眠用中药药膳 |
CN110839728A (zh) * | 2019-11-15 | 2020-02-28 | 刘永 | 一种人参酸枣仁安神增强免疫力养生茶及其制备方法 |
CN110772595A (zh) * | 2019-11-18 | 2020-02-11 | 黄泽昊 | 一种药食同源组合物及其制备方法和应用 |
CN111714581A (zh) * | 2020-07-22 | 2020-09-29 | 江西仁仁健康产业有限公司 | 一种助眠酵素及制备方法 |
CN113244367A (zh) * | 2021-06-02 | 2021-08-13 | 膳行天下(吉林)科技发展有限公司 | 一种供高血脂人群食用的药膳 |
CN113841892A (zh) * | 2021-09-24 | 2021-12-28 | 山西凉方科技有限公司 | 具有助眠功能的食品配方及制备方法和应用 |
Non-Patent Citations (2)
Title |
---|
曹路: "顽固性失眠辨治验案三则", 《贵阳中医学院学报》 * |
王志红: "安神饮治疗不寐临床体会", 《河北中医》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113243531A (zh) * | 2021-06-02 | 2021-08-13 | 膳行天下(吉林)科技发展有限公司 | 一种供高尿酸人群食用的药膳 |
CN114376039A (zh) * | 2021-12-25 | 2022-04-22 | 宁波荟康生命科技有限公司 | 一种用于安神、改善睡眠的复合果茶及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100425274C (zh) | 一种治疗失眠症的中药药物 | |
CN113331415A (zh) | 一种供睡眠障碍人群食用的药膳 | |
CN103800639A (zh) | 一种具有降糖、降脂、降压功效的药物组合物 | |
CN104873745B (zh) | 一种治疗失眠的中药及制备方法 | |
CN110772595A (zh) | 一种药食同源组合物及其制备方法和应用 | |
CN101982138B (zh) | 怡神解郁药枕 | |
CN102614444A (zh) | 一种有效治疗酒醉综合症的口服液 | |
CN103099866A (zh) | 一种治疗焦虑、失眠的中药组合物及其制备方法 | |
CN106581460A (zh) | 一种治疗顽固性失眠的药物 | |
CN113262260A (zh) | 一种治疗失眠的冷敷凝胶 | |
CN111956701A (zh) | 补气益血、治疗亚健康、预防癌症的中药药物及制备方法 | |
CN108042755A (zh) | 一种用于治疗脾胃虚弱的内服中药组合物及其应用 | |
CN111249420A (zh) | 一种调治气郁体质的中药组合物及其制剂和应用 | |
CN109646526B (zh) | 一种用于治疗抑郁症的中药组合物及其制备方法 | |
CN110604783A (zh) | 一种治疗失眠的中药组合物饮品及其制备方法 | |
CN101366860B (zh) | 用于利眠袪斑的胶玫口服液 | |
CN102716307A (zh) | 治疗嗜睡症的熟附子中药制剂及制备方法 | |
CN104547131A (zh) | 一种治疗面肌痉挛中药组合物 | |
CN107737319A (zh) | 改善睡眠质量的中药制剂及其制备方法 | |
CN105796943A (zh) | 足浴药袋 | |
CN107375574A (zh) | 一种治疗心脏神经官能症的中药组合物及其应用 | |
CN103989936B (zh) | 一种亚健康调理液及其制备方法 | |
CN103638323B (zh) | 治疗慢性萎缩性胃炎的中药丸剂 | |
CN106177437B (zh) | 一种改善女性阳虚体寒的玛咖组合物 | |
CN105012732B (zh) | 一种用于治疗睡眠障碍综合征的中药丸剂及制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20220720 Address after: 130000 group 7, Da Shi Jia Wo Bao Tun, Chengguang village, Changde street, Kuancheng District, Changchun City, Jilin Province Applicant after: Zhao Tian Address before: 130000 room 1001, building 23, Zone G, phase II, blue harbor, No. 759, Huigong Road, Erdao District, Changchun City, Jilin Province Applicant before: Shanxingtianxia (Jilin) Technology Development Co.,Ltd. |
|
TA01 | Transfer of patent application right | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20210903 |
|
WD01 | Invention patent application deemed withdrawn after publication |